Greenspace Health secures Series B funding from ABS Capital Partners to advance its Measurement-Based Care technology and transform behavioral healthcare delivery.
Target Information
Greenspace Health is a leading provider of Measurement-Based Care (MBC) technology, operating within the software as a service (SaaS) sector. The company has successfully implemented its platform in over 500 locations, completing more than 5 million assessments across various healthcare settings, including clinics, hospitals, and community organizations. Greenspace aims to enhance the clinical outcomes and care quality in behavioral healthcare through data-driven insights and operational efficiencies.
By empowering behavioral health providers with measurement tools, Greenspace facilitates the transition to value-based care, ensuring that both patients and providers benefit from enhanced engagement and improved outcomes. The significance of Greenspace’s innovative solutions lies in their ability to transform behavioral healthcare dynamics, making them a vital player in this evolving landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the United States
The behavioral healthcare industry in the United States is undergoing a significant transformation as the demand for high-quality, outcomes-driven care continues to rise. Traditional models of care are being replaced by value-based care frameworks that prior
Similar Deals
ARCH Venture Partners, GV (Google Ventures) → Pelage Pharmaceuticals
2025
Goldman Sachs Alternatives → evolvedMD
2025
EQT Life Sciences, Sanofi Ventures → SpliceBio
2025
Blue Owl Capital → Latigo Biotherapeutics
2025
ABS Capital Partners
invested in
Greenspace Health
in 2025
in a Series B deal